ANTM - Elevance Health Inc.

ANTM

$482.58 +12.71 (+2.71%) Last updated: Apr 16, 2026 00:45

52-Week Range

$482.58

$386.06 $482.58 $579.10

Fundamentals Overview

Elevance Health Inc. is in the middle of its 52-week range with moderate valuation, trending upward today.

Valuation moderate

P/E 20.8 P/B 1.57 P/S 0.34

Profitability

Net margin 2.8%

Risk (Beta)

0.97 — in line vol

Earnings & growth

EPS $23.26 Rev -1.9% Profit -54% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 35% confidence Risk: Moderate Volatility — Beta 0.97. Diversify and only invest what you can afford to lose.

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$114.59B

P/E (TTM)

20.75

EPS (TTM)

$23.26

Dividend Yield

2.2%

52-Week Range

$386.06 - $579.10

Volume vs Avg

N/A

Beta

0.97

About

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional i...

Sector: Healthcare

Headquarters: US

Employees: 98,200

IPO Date: Oct 2001

Website: www.antheminc.com

Beta: 0.97 (Less volatile than market)

Ratings & Grades at a Glance

Recent institutional grades: mixed. Current institutional positions: Buy: 8, Equal Weight: 1, Neutral: 2, Outperform: 4, Overweight: 10, Perform: 5.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	20.75
PEG (TTM)	N/A
P/B (TTM)	1.57
P/S (TTM)	0.34
P/FCF (TTM)	21.64
Liquidity & enterprise
Current Ratio (TTM)	1.24
Quick Ratio (TTM)	1.24
Cash Ratio (TTM)	0.48
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	2.84%
Gross margin (TTM)	25.56%
Operating margin (TTM)	4.07%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ANTM.

Analyst Sentiment at a Glance

Sentiment Mixed

Buy 8Equal Weight 1Neutral 2Outperform 4Overweight 10Perform 5

1 upgrade, 1 downgrade

Price Target Consensus

Current $482.58

Median $544.00

Consensus $529.05

Low consensus $335.00

High consensus $625.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Morgan Stanley	downgrade	Overweight	Equal Weight	2022-06-22
Loop Capital	maintain	Buy	Buy	2022-06-17
Wells Fargo	maintain	Overweight	Overweight	2022-05-25
BMO Capital	maintain	Outperform	Outperform	2022-04-25
Deutsche Bank	maintain	Buy	Buy	2022-04-22
SVB Leerink	maintain	Market Perform	Perform	2022-04-21
Credit Suisse	maintain	Outperform	Outperform	2022-04-21
Goldman Sachs	maintain	Buy	Buy	2022-04-21
Morgan Stanley	maintain	Overweight	Overweight	2022-04-21
UBS	maintain	Buy	Buy	2022-03-29
SVB Leerink	maintain	Market Perform	Perform	2022-03-15
Argus Research	maintain	Buy	Buy	2022-02-07
Morgan Stanley	maintain	Overweight	Overweight	2022-01-28
SVB Leerink	maintain	Market Perform	Perform	2022-01-27
Mizuho	upgrade	Neutral	Buy	2021-12-20
Morgan Stanley	maintain	Overweight	Overweight	2021-12-17
Mizuho	maintain	Neutral	Neutral	2021-10-29
Wells Fargo	maintain	Overweight	Overweight	2021-10-25
Morgan Stanley	maintain	Overweight	Overweight	2021-10-21
SVB Leerink	maintain	Market Perform	Perform	2021-10-21
Stephens & Co.	maintain	Overweight	Overweight	2021-10-21
Credit Suisse	maintain	Outperform	Outperform	2021-10-21
RBC Capital	maintain	Sector Perform	Perform	2021-10-21
Morgan Stanley	maintain	Overweight	Overweight	2021-08-31
Stephens & Co.	maintain	Overweight	Overweight	2021-07-22
Jefferies	maintain	Buy	Buy	2021-07-22
Mizuho	maintain	Neutral	Neutral	2021-07-22
Barclays	maintain	Overweight	Overweight	2021-07-22
BMO Capital	maintain	Outperform	Outperform	2021-07-22
Seaport Global	maintain	Buy	Buy	2021-07-09